Approvals/CIMA-AEMPS/FLUTICASONA TEVA 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

FLUTICASONA TEVA 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 36bf88fc3c4861bc
Drug Cima Aemps Name: FLUTICASONA TEVA 27,5 MICROGRAMOS/PULVERIZACION, SUSPENSION PARA PULVERIZACION NASAL
Register Number: 89694
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2024-07-09
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 27,5 microgramos/pulverización
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

FLUTICASONA FUROATO

0,5 mg/g

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 9, 2024

Approval ID

36bf88fc3c4861bc

Type

Standard